{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:45:38Z","timestamp":1791099938823,"version":"4.1.0"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            LasA protease is a staphylolytic endopeptidase secreted by\n            <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n            . We have examined the effectiveness of LasA protease in the treatment of staphylococcal keratitis caused by methicillin-sensitive\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            (MSSA) and methicillin-resistant\n            <jats:italic>S. aureus<\/jats:italic>\n            (MRSA) isolates in a rabbit model. Keratitis was induced by intrastromal injection of the bacteria. The eyes were treated topically, and the efficacy of LasA protease was compared to those of lysostaphin (a staphylolytic protease secreted by\n            <jats:italic>Staphylococcus simulans<\/jats:italic>\n            ) and vancomycin. When treatment was initiated early (4 h) after infection, practically all of the MSSA- and MRSA-infected corneas were sterilized by LasA protease, and its efficacy in eradicating the bacteria was comparable to those of lysostaphin and vancomycin. By contrast, most of the control corneas were heavily infected, with median values of 4.5 \u00d7 10\n            <jats:sup>6<\/jats:sup>\n            (MSSA) and 5 \u00d7 10\n            <jats:sup>5<\/jats:sup>\n            (MRSA) CFU\/cornea (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001). When treatment was initiated late (10 h) after infection, LasA protease reduced the numbers of CFU in both MSSA- and MRSA-infected corneas by 3 to 4 orders of magnitude compared to the numbers of CFU for the controls (median values, 1,380 and 30 CFU\/cornea, respectively, for the treated animals compared to 1.2 \u00d7 10\n            <jats:sup>6<\/jats:sup>\n            and 5 \u00d7 10\n            <jats:sup>5<\/jats:sup>\n            CFU\/cornea for the respective controls [\n            <jats:italic>P<\/jats:italic>\n            = 0.001]), and it was more effective than vancomycin in eradicating MRSA cells (\n            <jats:italic>P<\/jats:italic>\n            = 0.02). In both the early- and the late-treatment protocols, the clinical scores for eyes treated with LasA protease were significantly lower than those for the eyes of the corresponding controls and comparable to those for the lysostaphin- and vancomycin-treated eyes. We conclude that LasA protease is effective in the treatment of experimental\n            <jats:italic>S. aureus<\/jats:italic>\n            keratitis in rabbits and may have potential for the treatment of disease in humans.\n          <\/jats:p>","DOI":"10.1128\/aac.48.5.1681-1687.2004","type":"journal-article","created":{"date-parts":[[2004,4,22]],"date-time":"2004-04-22T19:58:16Z","timestamp":1082663896000},"page":"1681-1687","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":45,"title":["<i>Pseudomonas aeruginosa<\/i>\n            LasA Protease in Treatment of Experimental Staphylococcal Keratitis"],"prefix":"10.1128","volume":"48","author":[{"given":"Irina S.","family":"Barequet","sequence":"first","affiliation":[{"name":"Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Tel Aviv University Sackler Faculty of Medicine, Tel-Hashomer 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy J.","family":"Ben Simon","sequence":"additional","affiliation":[{"name":"Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Tel Aviv University Sackler Faculty of Medicine, Tel-Hashomer 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Safrin","sequence":"additional","affiliation":[{"name":"Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Tel Aviv University Sackler Faculty of Medicine, Tel-Hashomer 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Ohman","sequence":"additional","affiliation":[{"name":"Medical College of Virginia Campus of Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia 23298-0678"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Kessler","sequence":"additional","affiliation":[{"name":"Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Tel Aviv University Sackler Faculty of Medicine, Tel-Hashomer 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00179-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1076\/ceyr.22.4.266.5509","volume":"22","year":"2001","unstructured":"Alionte, L. G., B. M. Cannon, C. D. White, R. J. Caballero, R. J. O'Callaghan, and J. A. Hobden. 2001. Pseudomonas aeruginosa LasA protease and corneal infections. Curr. Eye Res.22:266-271.","journal-title":"Curr. Eye Res."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1982.01030030079005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00859.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(89)90046-6"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3109\/02713689209015083","volume":"11","year":"1992","unstructured":"Callegan, M. C., J. M. Hill, M. S. Insler, J. A. Hobden, and R. J. O'Callaghan. 1992. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr. Eye. Res.11:1111-1119.","journal-title":"Curr. Eye. Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00003088-199427020-00005","volume":"27","year":"1994","unstructured":"Callegan, M. C., R. J. O'Callaghan, and J. M. Hill. 1994. Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin. Pharmacokinet.27:129-149.","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1355"},{"key":"e_1_3_2_10_2","first-page":"1432","volume":"41","year":"2000","unstructured":"Dajcs, J. J., E. B. Hume, J. M. Moreau, A. R. Caballero, B. M. Cannon, and R. J. O'Callaghan. 2000. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Investig. Ophthalmol. Vis. Sci.41:1432-1437.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.22.6.451.5486"},{"key":"e_1_3_2_12_2","first-page":"3712","volume":"43","year":"2002","unstructured":"Dajcs, J. J., B. A. Thibodeaux, D. O. Girgis, M. D. Shaffer, S. M. Delvisco, and R. J. O'Callaghan. 2002. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Investig. Ophthalmol. Vis. Sci.43:3712-3716.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200104001-00007"},{"key":"e_1_3_2_14_2","first-page":"62","volume":"41","year":"1968","unstructured":"Dixon, R. E., J. S. Goodman, and M. G. Koenig. 1968. Lysostaphin; an enzymatic approach to staphylococcal disease. III. Combined lysostaphin-methicillin in therapy of established staphylococcal abscesses in mice. Yale J. Biol. Med.41:62-68.","journal-title":"Yale J. Biol. Med."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00716-2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.22.6608-6617.1996"},{"key":"e_1_3_2_17_2","first-page":"110","volume":"7","year":"1967","unstructured":"Harris, R. L., A. W. Nunnery, and H. D. Riley. 1967. Effects of lysostaphin on staphylococcal carriage in infants and children. Antimicrob. Agents Chemother.7:110-112.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1139\/m67-011","volume":"13","year":"1967","unstructured":"Harrison, E. F., and C. B. Cropp. 1967. Therapeutic activity of lysostaphin in experimental staphylococcal infections. Can. J. Microbiol.13:93-97.","journal-title":"Can. J. Microbiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/10445490260099674"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0076-6879(95)48050-1","volume":"248","year":"1995","unstructured":"Kessler, E. 1995. \u03b2-Lytic endopeptidases. Methods Enzymol.248:740-756.","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53203-8"},{"key":"e_1_3_2_22_2","first-page":"1476","year":"1998","unstructured":"Kessler, E., and D. E. Ohman. 1998. Staphylolysin, p. 1476-1478. In A. J. Barrett, N. D. Rawlings, and J. F. Woessner (ed.), Handbook of proteolytic enzymes, 1st ed. Academic Press, London, United Kingdom.","journal-title":"Handbook of proteolytic enzymes, 1st ed."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.15.9884"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.46.30225"},{"key":"e_1_3_2_25_2","first-page":"159","year":"1998","unstructured":"Liesegang, T. J. 1998. Bacterial and fungal keratitis, p. 159-219. In H. E. Kaufman, B. A. Baron, and M. B. McDonald (ed.), The cornea, 2nd ed. Butterworth-Heinemann, Boston, Mass.","journal-title":"The cornea, 2nd ed."},{"key":"e_1_3_2_26_2","first-page":"545","volume":"115","year":"1993","unstructured":"Maffett, M., and D. M. O'Day. 1993. Ciprofloxacin-resistant bacterial keratitis. Am. J. Ophthalmol.115:545-546.","journal-title":"Am. J. Ophthalmol."},{"key":"e_1_3_2_27_2","first-page":"55","volume":"49","year":"1987","unstructured":"Mansito, T. B., M. A. Falcon, J. Moreno, A. Carnicero, and A. M. Gutierrez-Navarro. 1987. Effects of staphylolytic enzymes from Pseudomonas aeruginosa on the growth and ultrastructure of Staphylococcus aureus.Microbios49:55-64.","journal-title":"Microbios"},{"key":"e_1_3_2_28_2","unstructured":"O'Brien T. P. 1997. Bacterial keratitis p. 1139-1189. In J. H. Krachmer M. J. Mannis and E. J. Holland (ed.) Cornea and external disease: clinical diagnosis and management. Mosby-Year Book St. Louis Mo."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1754"},{"key":"e_1_3_2_30_2","first-page":"85","volume":"30","year":"1985","unstructured":"Perestelo, F. R., M. T. Blanco, A. M. Gutierre-Navarro, and M. A. Falcon. 1985. Growth inhibition of Staphylococcus aureus by a staphylolytic enzyme from Pseudomonas aeruginosa.Microbios Lett.30:85-94.","journal-title":"Microbios Lett."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3086-3090.1997"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.22.3.446-450.1971"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.7.842"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.51.3.414"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.3.430-438.2002"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1432-1327.2001.01967.x","volume":"268","year":"2001","unstructured":"Vessillier, S., F. Delorme, J. Bernillon, J. Saulnier, and J. Wallach. 2001. Hydrolysis of glycine-containing elastin pentapeptides by LasA protease, a metalloelastase from Pseudomonas aeruginosa.Eur. J. Biochem.268:1049-1057.","journal-title":"Eur. J. Biochem."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.56.012302.160806"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00003226-200108000-00017","volume":"20","year":"2001","unstructured":"White, C. D., L. G. Alionte, B. M. Cannon, A. R. Caballero, R. J. O'Callaghan, and J. A. Hobden. 2001. Corneal virulence of LasA protease-deficient Pseudomonas aeruginosa PAO1. Cornea20:643-646.","journal-title":"Cornea"},{"key":"e_1_3_2_39_2","first-page":"309","volume":"16","year":"1972","unstructured":"Zygmunt, W., and P. A. Tavormina. 1972. Lysostaphin: model for a specific enzymatic approach to infectious disease. Prog. Drug Res.16:309-333.","journal-title":"Prog. Drug Res."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1681-1687.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1681-1687.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:20:30Z","timestamp":1645467630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.5.1681-1687.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1128\/AAC.48.5.1681-1687.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.5.1681-1687.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"2003-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}